• 1. An integrated system for field analysis of Cd(ii) and Pb(ii) via preconcentration using nano-TiO2/cellulose paper composite and subsequent detection with a portable X-ray fluorescence spectrometer?
  Xiaofeng Lin RSC Adv., 2016,6, 9002-9006
• 2. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 3. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 4. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 5. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazinanes Piperazines

Introduction to 1,4-diazaspiro[5.5]undecane dihydrochloride (CAS No. 1159822-91-9)

1,4-diazaspiro[5.5]undecane dihydrochloride, identified by the chemical identifier CAS No. 1159822-91-9, is a compound of significant interest in the field of pharmaceutical chemistry and medicinal biology. This spirocyclic diamine derivative has garnered attention due to its unique structural properties and potential biological activities, making it a subject of extensive research in drug discovery and development.

The molecular structure of 1,4-diazaspiro[5.5]undecane dihydrochloride consists of a spirocyclic framework composed of two cycloalkane rings connected by a nitrogen atom, with additional substituents that contribute to its chemical reactivity and biological interactions. This distinctive architecture allows the compound to exhibit properties that are not commonly found in linear or planar diamines, which has sparked curiosity among researchers exploring novel pharmacophores.

In recent years, the study of spirocyclic compounds has seen considerable growth, particularly in the context of developing new therapeutic agents. The rigid three-dimensional structure of 1,4-diazaspiro[5.5]undecane dihydrochloride provides a stable scaffold that can be modified to target specific biological pathways. This has led to investigations into its potential applications in treating a variety of diseases, including neurological disorders, inflammation, and infectious diseases.

One of the most compelling aspects of 1,4-diazaspiro[5.5]undecane dihydrochloride is its ability to interact with biological targets in a manner that is both selective and potent. The spirocyclic core enhances binding affinity by optimizing the spatial orientation of functional groups, which is crucial for drug design. Researchers have leveraged this property to develop analogs with improved pharmacokinetic profiles and reduced side effects.

Recent studies have highlighted the compound's potential as an inhibitor of enzymes involved in cancer progression. The nitrogen-rich spirocycle is believed to disrupt key signaling pathways by competing with natural substrates or by inducing conformational changes in target proteins. Preclinical trials have demonstrated promising results in cell culture and animal models, suggesting that derivatives of 1,4-diazaspiro[5.5]undecane dihydrochloride could serve as lead compounds for new anticancer therapies.

The synthesis of 1,4-diazaspiro[5.5]undecane dihydrochloride presents unique challenges due to its complex stereochemistry. However, advances in synthetic methodologies have made it more feasible to produce high-purity samples for research purposes. Techniques such as transition-metal-catalyzed reactions and asymmetric synthesis have been employed to construct the spirocyclic core with high enantioselectivity, which is essential for evaluating its pharmacological activity.

The hydrochloride salt form of 1,4-diazaspiro[5.5]undecane dihydrochloride enhances its solubility in aqueous solutions, making it more suitable for formulation into pharmaceutical products. This property is particularly important for drug delivery systems that require oral or parenteral administration. The improved solubility also facilitates high-throughput screening assays, allowing researchers to rapidly assess the compound's interactions with various biological targets.

In conclusion, 1,4-diazaspiro[5.5]undecane dihydrochloride (CAS No. 1159822-91-9) represents a promising candidate for further exploration in medicinal chemistry. Its unique structural features and demonstrated biological activity make it a valuable tool for developing new therapeutic agents. As research continues to uncover additional insights into its mechanism of action and pharmacological properties, this compound is poised to play a significant role in the next generation of pharmaceutical innovations.

• 100416-32-8(Piperazine,2-(4-methylcyclohexyl)-)
• 145122-55-0(6,9-diazaspiro[4.5]decane dihydrochloride)
• 51461-88-2(7,15-Diazadispiro[5.1.5.3]hexadecane, 15-octadecyl-)
• 89020-64-4(7,15-Diazadispiro[5.1.5.3]hexadecane, 15-methyl-7-octadecyl-)
• 51461-89-3(7,15-Diazadispiro[5.1.5.3]hexadecane, 15,15'-(1,12-dodecanediyl)bis-)
• 53816-35-6(7,15-Diazadispiro[5.1.5.3]hexadecane, 15,15'-(1,4-butanediyl)bis-)
• 80883-83-6(7,15-Diazadispiro[5.1.5.3]hexadecane, 7,15-dimethyl-)
• 21430-14-8(7,15-Diazadispiro[5.1.5.3]hexadecane)
• 89020-72-4(7,15-Diazadispiro[5.1.5.3]hexadecane, 15-methyl-)
• 89020-63-3(7,15-Diazadispiro[5.1.5.3]hexadecane, 15,15'-(1,4-butanediyl)bis[7-methyl-)